The corpus luteum (CL) develops from the remnants of the ovulatory follicle and produces progesterone, required for maintenance of pregnancy in mammals. The differentiation of granulosal and thecal cells into luteal cells is accompanied by hypertrophy and hyperplasia of cells. As the CL matures, growth ceases and in ruminants, the tissue acquires the ability to undergo regression in response to prostaglandin F2alpha. The regulators of this transition are poorly understood. MicroRNA, which are posttranscriptional regulators of tissue development and function, are expressed in the CL. However, the pattern of their expression and their function during the transition from developing to functional CL is not known. The objectives of this study were to profile the expression of miRNA in developing versus mature bovine CL and determine effects of miRNA on bovine luteal cell survival and function. Knockdown of Drosha in midcycle (MC) luteal cells decreased progesterone and increased luteal cell apoptosis in the presence or absence of proinflammatory cytokines. Microarray analysis demonstrated that a greater number of miRNA were expressed in MC compared to D4 CL. Ingenuity pathway analysis (IPA) predicted that D4-specific miRNA regulate pathways related to carbohydrate metabolism, while MC-specific miRNA regulate pathways related to cell cycle and apoptosis signaling. Both predictions are consistent with a switch in the CL from a growing phase to a maintenance phase. One of the MC specific miRNA, miR-34a, was selected for further analysis. Increased concentrations of miR-34a in MC luteal cells resulted in decreased luteal cell proliferation, increased progesterone production, and inhibition of Notch1 and YY1 translation, but had no effect on luteal cell apoptosis. In conclusion, these data support a role for miRNA in general, and miR-34a in particular, in luteal formation and function.
INTRODUCTION
The corpus luteum (CL) is a transient ovarian structure that develops rapidly after ovulation. The function of the corpus luteum is to support pregnancy via the secretion of progesterone [1] [2] [3] . Following ovulation and in response to the luteinizing hormone (LH) surge, the follicle undergoes luteinization, which involves modulation of gene expression, extensive cellular proliferation, and differentiation of granulosal and thecal cells into large and small luteal steroidogenic cells, respectively [4] . During its development, the growth rate of the bovine CL is comparable to the fastest growing tumor [5] and it is insensitive to the luteolytic (cell death) signals of prostaglandin F2alpha (PGF2A). However, around Day 5 or 6, the bovine CL acquires luteolytic capacity (ability to regress in response to PGF2A) followed by cessation of growth and proliferation of cells [6] . The changes that regulate the switch from luteinization to maximum function and the acquisition of luteolytic capacity are poorly understood.
MicroRNA (miRNA) are short, single-stranded RNA (;22 nucleotides) that regulate gene expression and tissue development [7, 8] . By binding to specific sites within the 3 0 untranslated region (3 0 -UTR) of target messenger RNA (mRNA), miRNA downregulate gene expression by either repression of mRNA translation or by mRNA degradation. Occasionally, some miRNA have been found to enhance the translation of their target mRNA [9, 10] . As posttranscriptional regulators of mRNA, miRNA play a role in the regulation of tissue development and function.
Drosha (RNase III enzyme) and dicer (endoribonuclease) are two important enzymes in the miRNA production machinery. In the nucleus, DROSHA partners with diGeorge syndrome critical region gene 8 (DGCR8) to cleave the primary miRNA transcript into a 70nt stem loop pre-miRNA. Once exported into the cytoplasm, DICER further cleaves the pre-miRNA to produce a double-stranded miRNA. One or both strands of the double-stranded miRNA form a complex with Argonaute to target gene expression [11] . Alternatively, miRNA may also be generated by pathways that are independent of Drosha/DGCR8 or Dicer [12, 13] . Knockdown of DICER1 in mice resulted in infertility due to aberrant luteal angiogenesis and failure of the CL to form [14] . MicroRNA are evolutionarily conserved and are expressed in the corpus luteum of several species [15, 16] . However, the profile of miRNA expression during the transition from developing to mature CL is not yet known.
MicroRNA-34a is a member of the miR-34 family (including miR-34b and miR-34c), which is known to play a role in cancer and apoptosis [17] . MiR-34a targets an array of genes involved in apoptosis, cell proliferation, migration, and differentiation. MiR-34a is one of several miRNA that induce apoptosis in porcine granulosal cells [18] , and its expression increases during the follicular-luteal transition in sheep [15] . However, the expression pattern of miR-34a in the corpus luteum is not yet known. The aims of this study were to profile miRNA expression in the developing versus mature CL, determine miR-34a targets in luteal cells, and test the hypothesis that miR-34a regulates luteal cell proliferation, survival, and function.
MATERIALS AND METHODS

Luteal Tissue Collection and Luteal Cell Isolation
For microarray experiments, the estrous cycle was synchronized in 6 cows using vaginally inserted control internal drug release (CIDR; Pharmacia and Upjohn) devices that release progesterone and injections of 25 mg of PGF2A, commercially available as Lutalyse (Pharmacia and Upjohn). CIDR devices were inserted vaginally for a period of 7 days. PGF2A injection was administered on Day 6, one day before CIDR removal, to induce luteal regression. The three cows designated for developing (Day 4) corpus luteum (CL) collection received an injection of gonadotropin releasing hormone (GnRH; Factrel; Zoetis) 72 h after CIDR removal and were slaughtered 4 days later. The three cows designated for midcycle (MC) CL collection were observed after CIDR removal to determine the onset of estrus, and on Days 9 to 12 of the estrous cycle, the CL was collected by colpotomy. All corpora lutea were quartered and immediately frozen in liquid nitrogen and stored at À808C. For cell culture experiments, corpora lutea were collected by colpotomy from cyclic cows during the MC (Days 9-12; Day 0 ¼ day of estrus). Each CL was dissociated according to the procedure described previously [19] . Cells were subjected to decreasing speeds of centrifugation during washes to separate the steroidogenic cells from endothelial, fibroblastic, and immune cells. Each experiment was repeated 3 to 5 times. Handling of animals and surgical procedures were conducted according to protocols approved by the Institutional Animal Care and Use Committee (IACUC) at Pennsylvania State University, Pennsylvania.
RNA Interference and Luteal Cell Transfection
For RNA interference experiments, two pairs of siRNA duplexes (I and II) ( Table 1) were used each for DICER1 and for DROSHA (Life Technologies). To confirm homology to the target, sequences were analyzed using BLAST (National Center for Biotechnology Information; http://www.ncbi.nlm.nih.gov/). A commercially available nonsilencing scrambled (SCR) siRNA (Life Technologies) was used as a negative control. Luteal cells were transfected on the day of collection using a Nucleofector 2b device (Lonza Inc.) and the Basic Mammalian Epithelial Cell kit (Lonza) according to the manufacturer's protocol. After transfection, luteal cells were plated in 24-well plates and cultured in serum-free growth medium (Ham F-12 medium supplemented with gentamicin [20 lg/ml], L-glutamine [200 nM], insulin-transferrin-selenium [ITS; insulin and transferrin, 5 lg/ml each, and selenium, 5 ng/ml]; Corning Inc.) in the absence or presence of LH (10 ng/ml; Fitzgerald Industries). For miRNA inhibition or augmentation, luteal steroidogenic cells were transfected with miR34a LNA inhibitor (Exiqon) or mimic (Life Technologies), respectively, at 12 to 24 h after plating, using Mirus TKO reagent (Mirus Bio LLC) according to the manufacturer recommendations. Luteal steroidogenic cells were transfected in the presence of 10% fetal bovine serum for 16 to 18 h. Transfection medium was removed, and cells were replenished with serum-free growth medium supplemented with LH (2.5 ng/ml) for the remainder of the experiment. To assess transfection efficiency, we tranfected luteal cells with Cy3-labeled siRNA (Life Technologies), and fluorescence was measured by flow cytometry. More than 70% of cells were fluorescently labeled with a mean fluorescence 7-fold greater than the untransfected negative control. Cells and media were collected at times indicated in Results.
Cell Treatments
For progesterone measurement, cells were transfected with 50 nM miR-34a or negative control mimics (Life Technologies) and cultured for 7 days in serum-free Ham F-12 medium supplemented as described above. Medium was collected, and new medium was added on Days 1, 3, and 5. For miR-34a expression, luteal cells were treated on Day 0 of culture with LH (10 ng/ml), PGF2A (10 ng/ml; Sigma-Aldrich), TGFB1 (1 ng/ml; Sigma-Aldrich), tumor necrosis factor (TNF; 50 ng/ml; R&D Systems) or a combination of TNF and LH or TNF and IFNG (500 ng/ml; R&D Systems). After 24 h, total RNA was extracted and assayed by reverse transcription and quantitative polymerase chain reaction (qPCR). To assess the effect of progesterone on miR-34a expression, luteal cells were treated with aminoglutethimide (AG; 50 lg/ml, on Day 0 and Day 1 of culture; Sigma-Aldrich) in the presence of increasing concentrations of progesterone (P 4 ; 0, 1.2, 2.5, and 5 lM; Sigma-Aldrich). On Day 3 of culture, medium and cells were collected for analysis.
MicroRNA Isolation, Labeling, and Microarray Analysis
MicroRNA were isolated from frozen luteal tissue using the miRVana miRNA isolation kit (Life Technologies) according to the manufacturer's protocol. RNA quality was examined using an Bioanalyzer (Agilent Technologies). RNA with quality index (RIN) .8 were polyadenylated and biotinylated using Flash Tag biotin RNA labeling kit (Genisphere Inc.). Labeled miRNA were hybridized to miRNA microarray chip (Genechip; Affymetrix) and miRNA expression levels on Day 4 were compared with those on MC (Days 9-12) CL. Affymetrix chips included a total of 7788 sequences, of which 6703 sequences were miRNA, 900 were small nucleolar RNA (snoRNA), 499 were snoRNA, 274 were CDbox; and 127 were H/ACA box snoRNA, 22 were small cajal body-specific RNA (scaRNA), and 10 were 5.8s rRNA. Affymetrix control sequences (131 probes) and oligonucleotide spike-in controls (22 probes) were included for background and microarray quality check. MicroRNA probes used represented 72 different species including mammalian, birds, fish, insects, viruses, and plant species. Only 125 identified bovine miRNA were included on the chip. Because miRNA sequences are highly conserved, identification of additional bovine miRNA relied on heterologous probes on the array. Microarray Dat files were converted to Cel files, normalized to background controls, and analyzed using miRNA QC Tools software (Affymetrix). Background hybridization value cutoff was 4. Intensities with a P value of 0.06 were considered true values (above background). Labeling controls (Genisphere) and hybridization control probes were used to determine successful labeling and efficient hybridization of RNA samples to microarray chips, respectively. Only miRNA with true values in all three replicates of either developing (D4) and/or MC CL were further analyzed.
Qiagen Ingenuity Pathway Analysis
Network generation and functional analyses were generated through the use of the core analysis function in Ingenuity Pathway Analysis (IPA) (Qiagen). MicroRNA identifiers and corresponding expression values were uploaded into the core analysis application. Each identifier was mapped to its corresponding object in Ingenuity's Knowledge Base feature. A P value of ,0.05 was set to identify molecules with differentially regulated expression. Network Eligible molecules were overlaid onto a global molecular network developed from information contained in Ingenuity's Knowledge Base. Networks of Network Eligible molecules were then algorithmically generated based on their connectivity. Functional analysis identified the biological functions that were most significant to the data set. Right-tailed Fisher exact test was used to calculate a P value that determined the probability that each biological function and/or disease assigned to that data set is due to chance alone Total RNA Extraction, PCR, and Quantitative PCR Total RNA were extracted using the miRVANA miRNA isolation kit (Life Technologies) according to the manufacturer's protocol. RNA quality was examined using Experion automated electrophoresis system (Bio-Rad). Samples with RNA quality index (RQI) of .9 (best RQI ¼ 10) were treated with RNase-free DNase (Promega), and reverse transcribed using the DyNAmo cDNA synthesis kit (Life Technologies). Quantitative PCR was performed using SensiMixPlus SYBR kit (Bioline) and the 7500 Fast Real-Time PCR system (Applied Biosystems) for 40 cycles for DICER1, DROSHA, and ribosomal protein L19 (RPL19). Primer sets for DICER1 were 5 0 -TCCGGCTTCACGTTATCTCT-3 0 and 5 0 -TCAATGTCCAAAGTGCTGGA-3 0 , and those for DROSHA were 5 0 -GGAGATTGCCAATATGCTTCA-3 0 and 5 0 -GGACAGAGCTTGGTTTCGTC-3 0 . For miRNA quantification, DNasetreated RNA were reverse transcribed using an miRCURY LNA Universal cDNA synthesis kit (Exiqon). This is a two-step reverse transcription reaction that consists of extension of the mature miRNA template by adding a poly-A tail, followed by the synthesis of the cDNA using a poly-T tail with a 5 0 universal tag and a 3 0 degenerate anchor. Quantitative PCR was performed using a Universal RT microRNA PCR system, using LNA-miR-34a and miR30b primers and SYBR Green for detection (Exiqon). MiR-30b was used as a reference miRNA because its expression did not differ between Day 4 and MC CL or between Days 1 and 7 of cultured cells.
In Situ Hybridization
Immediately after collection, pieces of luteal tissue were fixed overnight at 48C in freshly prepared 4% paraformaldehyde solution. Tissues were transferred to a 30% sucrose solution and kept at 48C overnight. Fixed and cryopreserved tissues were embedded in optimum cutting temperature solution and flash frozen in isopentane at À808C. Tissue sections (10 lm thick) were probed for miR-34a by using miRCURY LNA miRNA in situ hybridization (ISH) optimization kit (Exiqon) according to the manufacturer's protocol. Both scrambled probe and no probe were used as negative controls and showed no purple staining in either group. U6 small nuclear RNA was used as a technical positive control. Photos were collected using a BX51 model microscope and DP71 digital camera (Olympus).
Northern Blot Analysis
Nonradioactive Northern blotting for detection of small RNA was adapted from Kim et al. [20] . Briefly, total RNA were migrated on Pro-Tean 3 vertical gel system (Bio-Rad). Migrated RNA were transferred onto positively charged nylon membranes (Roche) and cross-linked using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (catalog no. 7750; Sigma-Aldrich) cross-linking solution. Digoxin (DIG)-labeled locked nucleic acid (LNA)-miR-34a or scrambled RNA probes (Exiqon) were hybridized to the membrane using ULTRAhyb ultrasensitive hybridization buffer (Life Technologies). After being washed and blocked, RNA-bound DIG-labeled probes were targeted by alkaline phosphatase (AP)-conjugated DIG antibody. AP substrate, CSPD (Roche) was used to detect the presence of target small RNA. A scrambled control was used to verify the specificity of the miR-34a signal.
Western Immunoblot Analysis
Proteins were extracted from tissues or cultured cells by using CelLytic MT cell lysis reagent (Sigma-Aldrich) in the presence of protease inhibitor cocktail (Sigma-Aldrich) following the manufacturer's instructions. Proteins were separated using SDS-PAGE and blotted onto polyvinylidene difluoride (PVDF; Hybond-P, GE Healthcare) membranes. Western analyses were performed using polyclonal rat anti-NOTCH1 (Cell Signaling), polyclonal rabbit antiYing Yang 1 (YY1) (Proteintech Inc.), and polyclonal rabbit anti-caspase 3 (CASP3) (Enzo Life Sciences Inc.). Beta-actin (Sigma-Aldrich) was used as a loading control. Bands were detected and quantified using ChemiDoc XRS software (Bio-Rad).
Luciferase Assay
The firefly luciferase reporter vectors pMiRLuc (FLuc) and pMiR-34a-Luc (34aFLuc) were purchased from Signosis. The pMiR-34a-Luc reporter vector has the same backbone of pMiRLuc except for a miR-34a binding sequence in the 3 0 -UTR of the firefly luciferase gene. The pGL4.75 (hRluc/CMV) Renilla luciferase vector (RLuc) and dual-luciferase reporter assay system were purchased from Promega. Luteal cells were cotransfected with 100 ng of 34aFluc and RLuc vectors alone or in the presence of the miR-34a inhibitor (250 nM) or mimic (100 nM) or their respective negative controls. Renilla luciferase vector was used as an internal normalizer to account for variation in transfection efficiency. Luciferase activity was assayed 24 h after transfection according to the manufacturer's protocol. Cells transfected with Fluc and Rluc were used as a control for the luciferase assay and as a reference to measure the activity of endogenous miR-34a in luteal cells.
Proliferation Assay
Luteal cells were seeded at 125 000 cells/well in a 12-well plate. These cultures contained ;90% steroidogenic cells, most of which were small, thecalderived cells and some of which were large, granulosa-derived cells. Cells were transfected as above but only for 4 h because longer exposure to TKO transfection reagent was detrimental to luteal cell proliferation. Transfection medium was replaced with the same medium described above, supplemented with 10% fetal bovine serum. Starting on Day 1 (the day of transfection) and until Day 7 of culture, cells were counted under a 203 objective using a Whipple disk (1 3 1 cm) ocular, and the average number of cells per field was multiplied by the equivalent Whipple disk area of the well. Cells were stained for 3-beta-hydroxysteroid dehydrogenase (HSD3B) on Days 1 and 7 of culture. Conditioned medium of cultured luteal steroidogenic cells was stored at À208C for progesterone analysis. Progesterone concentrations were analyzed by ELISA, as previously validated in this laboratory [21] .
Mitopotential Assay
The percentages of depolarized (dying) and apoptotic luteal cells were determined using the Guava mitochondrial depolarization kit (EMD; Millipore). This assay allows measurement of early mitochondrial depolarization [22] and late apoptosis. Luteal cells were incubated with 4 ll of a 1:1 (v:v) mixture of JC-1 and 7-amino actinomycin D (7-AAD), to a final concentration of 13 per well.
Statistical Analysis
Microarray data were analyzed using the miRNA QC Tools microarray software (Affymetrix). This software uses Wilcoxon rank-sum test for replicate probe sets. MicroRNA were considered expressed if the average probe hybridization P value was 0.06. Only miRNA that had a true value in all three replicates were analyzed in this study. Data from the mitopotential assay and ELISA were analyzed using PROC-MIXED ANOVA analysis with Tukey adjustments when comparing more than two groups. Statistical data from the proliferation experiments were analyzed by repeated measures ANOVA with Tukey adjustments. Gene and protein expression data were analyzed using covariate analysis with RPL19 or beta-actin as the covariate. All experiments were repeated with CL from 3 or more animals, and the exact number of replicates for each experiment are indicated in Figures 1 to 3 .
RESULTS
Knockdown of DROSHA Decreases Progesterone Production and Increases Luteal Cell Death
Both DICER1 and DROSHA were expressed in luteal steroidogenic cells from MC CL (Fig. 1A) . Transfection of luteal cells with DROSHA and DICER1 siRNA resulted in a reduction of DROSHA and DICER1 mRNA (Fig. 1A) and protein (Fig. 1B) . DROSHA knockdown was more pronounced than DICER1 knockdown in both mRNA and protein assays; therefore, the role of DROSHA in luteal cell function and survival was further investigated. Knockdown of DROSHA decreased progesterone production by luteal cells (Fig. 1C) . As expected, the proportion of luteal cells that were apoptotic was increased by treatment with TNF/IFNG. Depletion of DROSHA in luteal cells increased the proportion of cells undergoing apoptosis (P , 0.05) when compared to the controls (untransfected cells or cells transfected with scrambled siRNA) both in the absence and presence of TNF/IFNG (Fig. 1D) .
Analysis of microRNA Expression in Day 4 and MC Bovine CL
Comparison of developing (Day 4) CL to mature (MC; Days 9-12) CL using a microarray resulted in 231 expressed miRNA (Table 2) . Of these miRNA, 11 were dead entries in miRBase v. 21, having been reported erroneously as miRNA in previous versions. The remaining 220 miRNA were distributed as follows: 140 of the 220 were expressed in both stages of luteal development, 11 of the 220 (5%) were present only in Day 4 CL, and 69 of the 220 (31%) were present only in MC CL (Table 2 , Fig. 2 ; Supplemental Table S1 , available online at www.biolreprod.org). Overall, 49% of the 220 miRNA expressed in the CL, as determined by microarray analysis, were similar in concentration between Day 4 and MC CL, 5% were specific to Day 4 CL, 31% were specific to MC CL, and 15% were expressed in both stages but were upregulated in MC compared to Day 4 CL (Fig. 2) .
Of the 220 miRNA, 85 represented hybridization to species other than Bta and were not found as Bta miRNA in miRBase v. 21 . Some of these were the same as sequences on the opposite strand of the stem loop of a known Bta miRNA. Hence, these 85 miRNA are potential novel sequences for Bta (Table 2, Supplemental Table S1 ). Based on microarray analysis, 65 of the 85 potentially novel miRNA were commonly expressed in both Day 4 and MC CL, 9 were expressed only in Day 4, and 11 were expressed only in MC CL.
Expression Profiles of Known (Bos taurus) and Potentially Novel miRNA
Analysis of the Bta miRNA on the array revealed only 2 (miR-124 and miR-365) that were exclusive to the developing CL, although the hybridization value was 4.3, which was only slightly above the cutoff value of 4 and was considered not significantly different from the background. Fifty-eight miR-NA, 56 of which belonged to 43 miRNA gene families, were present only in MC CL. Seventy-five miRNA, belonging to 47 gene families, were present in both early and MC CL (Supplemental Table S1 , Fig. 3A) . Thirty of the 75 commonly expressed known miRNA were .1.5-fold upregulated in MC CL; the remaining 45 did not differ in expression between the two stages of the estrous cycle (Fig. 3B) .
Of the 85 potentially novel miRNA for Bta (positive hybridization of samples to sequences from other species), 22 did not belong to any specific gene family, but the remaining 63 belonged to 48 gene families of miRNA (Supplemental Table S1 ). Nine miRNA were expressed only in Day 4 CL, and 11 were expressed only in MC CL. The remaining 65 were expressed in both Day 4 and MC CL at similar concentrations, except for miR-638 and miR-762, which were 1.5-fold upregulated in MC compared to Day 4 CL (Fig. 3, C and D) .
The most abundant miRNA in the CL were members of the let-7 family, in particular let-7b, with hybridization values .8 (P , 0.06; Supplemental Table S1 ). Expression of let-7b was abundant and slightly (1.3-fold) greater in MC CL. Only let-7g and miR-98 of the let-7 family had true hybridization values in Network analysis of Day 4 and MC miRNA in IPA showed that the top networks that involve miRNA in Day 4 CL were primarily related to carbohydrate metabolism, small molecule biochemistry, reproductive system disease, cancer, and cellular growth and proliferation. However, the top networks associated with the miRNA expressed in MC CL were primarily related to cell cycle, cell death, cell morphology, DNA replication, recombination and repair, and cellular development ( Table 3) .
Expression of miR-34a in Luteal Tissue and Cultured Cells
One of the microRNA that was expressed only in MC CL was miR-34a. MiR-34a targets genes involved in apoptosis and proliferation of normal and tumor cells. Because luteal cell proliferation decreases and the CL gains the capacity to undergo apoptosis in response to PGF2A upon transition from developing to mature CL, the role of miR-34a in luteal cells was further investigated. Quantitative PCR and Northern blot analysis confirmed that miR-34a was upregulated in MC compared to Day 4 CL (Fig. 4, A and B) . Furthermore, ISH analysis showed that miR-34a was distributed throughout the MC CL (Fig. 4C) . In cultured luteal cells, the expression of miR-34a increased between Days 1 and 7 of culture (Fig. 5A) . Expression of miR-34a was unchanged by treatment with LH, prostaglandins or cytokines for 24 h (Fig. 5B) . Further, to test the effect of progesterone on miR-34a expression, cells were treated with aminoglutethimide to inhibit progesterone, then progesterone was replenished at varying concentrations, with the highest concentration comparable to previously measured concentrations in luteal cell-conditioned culture medium. However, neither inhibition nor addition of progesterone to cultured luteal steroidogenic cells resulted in a change in the expression of miR-34a (Fig. 5C ).
Endogenous Activity of miR-34a in Luteal Steroidogenic Cells
Luciferase reporter vectors were used to investigate the activity of miR-34a in MC luteal cells. Cells were transfected with a vector expressing either firefly luciferase mRNA with a 3 0 -UTR modified to incorporate the miR-34a binding sequence (34aFLuc) or a vector expressing the unmodified luciferase transcript (FLuc). Luciferase activity was reduced by 59% in luteal cells transfected with 34aFLuc relative to cells transfected with FLuc (Fig. 6A) . Consistent with that observation, luteal cells cotransfected with 34aFLuc and a miR-34a mimic produced an 83% decrease in luciferase expression relative to cells transfected with 34aFLuc alone, or cotransfected with 34aFLuc and a negative control miR sequence (Fig. 6B) . Surprisingly, cells cotransfected with 34aFLuc and a locked nucleic acid (LNA) designed to target and knock down endogenous miR-34a did not restore luciferase activity to the level previously seen in cells transfected with FLuc (Fig. 6C) . All of the above transfection experiments included a Renilla luciferase expression vector (RLuc) for the purpose of normalizing data to eliminate transfection efficiency differences.
Role of miR-34a in Luteal Cell Proliferation, Function, and Survival
Mature, steroidogenic luteal cells can be induced to proliferate in vitro, albeit at a slow rate, by culturing them with 10% serum. In a preliminary experiment, no differences in the proportion of HSD3B-positive cells on Day 1 (77%) and Day 7 (81%) of culture were observed, confirming that steroidogenic cells were those that proliferated. MiR-34a has been described as a tumor suppressor miRNA. To test its role in luteal cell proliferation, miR-34a was overexpressed in luteal steroidogenic cells cultured in 10% serum. Use of a miR-34a mimic to increase intracellular concentration of miR-34a in luteal cells resulted in less cellular proliferation over 7 Days in culture (Fig. 7A) . The miR-34a mimic also increased progesterone secretion compared to the negative control group (Fig. 7B) , but similar to the result with luciferase expression, the miR-34a inhibitor had no effect on progesterone production (data not shown). There was no effect of the miR-34a mimic on luteal cell apoptosis as measured by either mitochondrial potential (Fig. 7C) or by cleavage of CASP3, another marker of apoptosis (Fig. 7D) .
MiR-34a Regulates NOTCH1 and YY1 in Luteal Steroidogenic Cells
Notch 1 and YY1 are confirmed targets of miR-34a [23] . Both Notch1 and YY1 are involved in luteal cell steroidogenesis [24] [25] [26] . The concentration of NOTCH1 mRNA was greater in luteal tissue collected during MC than that collected on Day 4 of the estrous cycle (Fig. 8A ), but this was not accompanied by a change in NOTCH1 protein concentration (Fig. 8, B and D) . YY1 protein was greater in MC than in D4 CL (Fig. 8, C and D) . 
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In cultured luteal steroidogenic cells, the concentration of NOTCH1 and YY1 proteins decreased with time in culture (Fig. 9) , which was opposite to the pattern of expression of miR-34a in the same cultured cells (Fig. 5A) . The miR-34a mimic decreased NOTCH1 and YY1 protein as early as 24h and up to 72h after transfection (Fig. 10) .
DISCUSSION
DICER1 and DROSHA are two important enzymes involved in miRNA biogenesis. DROSHA is specific to miRNA biogenesis, whereas DICER1 is also involved in the biogenesis of other small RNA, such as small interference RNA [13] . Otsuka et al. [14] showed that mice with hypomorphic DICER1 expression were infertile because they failed to develop corpora lutea, due to impaired angiogenesis. Hypomorphic DROSHA animal models have not been described, so an effect of DROSHA knockout on reproductive phenotype remains unknown. DROSHA and DICER1 were expressed in luteal cells isolated from MC CL. To our knowledge, this is the first study to examine DICER1 and DROSHA expression in the corpus luteum. Knockdown of DROSHA decreased progesterone production, increased luteal cell death by apoptosis, and further potentiated the apoptotic effects of TNF/IFNG, which have been previously shown to induce apoptosis in luteal steroidogenic cells [27] . The decrease in progesterone could be due to a direct effect of miRNA on the steroid biosynthetic pathway, or due to the loss of cells by apoptosis. This demonstrates a role for DROSHA, and therefore likely miRNA, in regulating survival and function of luteal steroidogenic cells.
Microarray analysis of miRNA expressed in D4 and MC CL resulted in a total of 220 miRNA that were expressed. Forty nine percent of the profiled miRNA were expressed at similar MAALOUF ET AL.
concentrations in both the developing and mature CL, indicating a potential role in regulating cell metabolic processes that are independent of the stage of the estrous cycle. Fifteen percent of the commonly expressed miRNA were upregulated in MC CL. However, these differences in expression require further validation by deep sequencing and/or qPCR. Overall, the number of miRNA expressed in MC CL was greater than that expressed in D4 CL, indicating that the transition from formation to function of the CL involves expression of a cadre of miRNA that likely regulate cellular proliferation and apoptotic potential. Network analysis confirmed that D4 miRNA were more likely to be involved in regulation of growth and metabolic pathways, whereas MC miRNA were more likely involved in cell cycle and cell death regulation, critical to mature luteal biology [6, 28, 29] . As the CL further differentiates between Day 4 and Day 5 of the estrous cycle, it gains the ability to undergo luteolysis in response to exogenously administered PGF2A . Therefore, upregulation of miRNA in the mature CL may result in changes in protein expression that are necessary for the acquisition of luteolytic capacity. In standard CIDR-based estrous synchronization protocols, the exact time of ovulation after CIDR removal is somewhat variable. During early luteal development, there are rapid changes in the tissue, which could introduce considerable variability to experimental data if the age of the CL was not the same. Therefore, cows from which Day 4 CL were collected received an injection of GnRH to ensure that ovulation occurred within a window of time that would allow for collection of a CL that would be considered as Day 4. GnRH was not administered to cows from which MC CL were collected, because the timing of ovulation was not critical. There is a slight possibility that the differences in miRNA expression observed in the present study could be due to ovulation in response to exogenous versus endogenous GnRH. In hindsight, it would have been preferable to also administer GnRH to those cows from which MC CL were collected. However, it is highly likely that the differences in miRNA observed in this study were due to developmental stage of the CL. Firstly, use of exogenous GnRH in estrous synchronization protocols results in formation of a CL that is normal in function and lifespan. Secondly, the pathway analyses of differentially expressed miRNA were completely consistent with the transformation of the tissue from a state of growth and proliferation to a state of cell cycle regulation and the ability to undergo apoptosis. Therefore, it is reasonable to assume that the differences in miRNA expression reported in this study are due to developmental events within the CL.
MicroRNA microarray analysis is a powerful tool to profile miRNA in a number of samples and within a reasonable period 
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of time. However, the interpretation of the results has to take into consideration the limitation of this technique [30, 31] . For instance, the annotated probes, used on the microarray chips in this study, were based on an earlier version of miRBase (miRBase v.18). Hence, the probe sequences are limited to those available in miRBase at the time of manufacture. As a result, 11 sequences that showed a positive hybridization in Luteal cells were transfected with 34aFLuc (Control) or cotransfected with 34aFLuc and a miR-34a mimic (miR-34a Mimic) or 34aFLuc and a negative control miR nucleotide sequence. (C) Attempt to deplete miR34a activity through exogenous addition of a targeted LNA. Luteal cells were transfected with 34aFLuc (Control) or cotransfected with 34aFLuc and a miR-34a LNA inhibitor (miR-34a Inhibitor) or 34aFLuc and a negative control miR LNA sequence. All cell transfections included a Renilla luciferase expression vector (RLuc) as an internal normalizer, and data are the firefly Luc/Renilla Luc luminescence ratio. Plotted data are mean 6 pooled SEM; N ¼ 3; P , 0.05.
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luteal tissues were removed and referred to as dead entries in miRBase v.21 database. Those sequences were not included in the analysis.
Furthermore, since microarray chips are designed based on known miRNA sequences, this method does not allow the identification of novel miRNA. However, use of a multispecies chip did allow for discovery of signals that may represent miRNA that are novel for Bos taurus. The present analysis resulted in 85 miRNA that were not previously described for the Bos taurus species. These miRNA were described for human, mice or other species but were new for Bta, or they were on the opposite strand of the stem loop of an already identified Bta miRNA. Those miRNA were designated as potentially novel for Bta (Supplemental Table S1 ). Although the bovine miRNA hybridized to heterologous miRNA on the chip, it remains to be determined by sequencing if the sequences are an exact match, or if the bovine tissues have slightly different isomiRs of the same miRNA. In addition, absolute quantification of the expression of these miRNA requires analysis by sequencing or qPCR.
MiR-34a is a tumor suppressor that regulates genes involved in cell proliferation, survival, and apoptosis [32] . MiR-34a also induces apoptosis and increases the sensitivity of tumor cells to chemotherapy [18, [33] [34] [35] [36] [37] . In breast cancer cells, miR-34a increased the sensitivity of tumor cells to paclitaxel by downregulating the Notch1 signaling pathway [38] . The increase in miR-34a as the CL matured supported a role for miR-34a in the cessation of luteal cell proliferation and acquisition of luteolytic capacity. Elucidation of the role of miR-34a in luteal cells was attempted using inhibition and enhancement of miR-34a. Increased activity of miR-34a in luteal cells by transfection with the miR-34a mimic revealed effects on steroidogenesis, cellular proliferation and expression of predicted target proteins. However, effects of the miR-34a inhibitor were not apparent.
Observation of an inhibitor effect of a particular miRNA sometimes requires inhibition of more than one miRNA that influence the same molecular pathway. Therefore, it is possible that effects of inhibition of miR-34a were not apparent without the modification of additional miRNA that act in concert with miR-34a. In our hands, the inhibitor produced quite variable 
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results, so it is also possible that the lack of downstream effects in these experiments may be due to failure to consistently inhibit miR-34a. We have also performed miRNA sequencing on luteal tissue [16] and have found the miR-34a exists as isomiRs, with the two most abundant isomiRs being almost equally expressed. Therefore, it is possible that this specific inhibitor only hybridized with one of the isomiRs, allowing the other one to continue to regulate target translation in the cells.
The miR-34a mimic decreased luteal cell proliferation but it neither induced luteal cell apoptosis nor increased the sensitivity of luteal cells to TNF/IFNG treatment, as was observed by knockdown of DROSHA. Although the present data do not support a role for miR-34a in luteal cell apoptosis, it is acknowledged that such a role is not completely ruled out from this experiment because the function of miRNA can be redundant and depend on the expression of other miRNA [39] . Another possibility is that the apoptosis that occurs during luteolysis in vivo is difficult to simulate in vitro. For example, in cattle, injection of PGF2A results in luteal regression, including apoptosis. But in cultures of steroidogenic luteal cells, PGF2a reduces steroidogenesis with no effect on cell viability. This may be due to the lack of cell heterogeneity in the cultures, e.g., no endothelial or immune cells. Of course, it is also possible that miR-34a does not regulate apoptotic pathways in the CL, although this would appear to be unique for the CL. Therefore, the current data support a role for miR34a in negative regulation of luteal cell proliferation, but these experiments did not provide evidence for a role of miR-34a in acquisition of luteolytic capacity. It would be of interest to determine if manipulation of additional miRNA that potentiate the effects of miR-34a would reveal a role in apoptosis in luteal cells. For instance, Let-7b, which was abundant in the CL according to the microarray data but was not further evaluated in culture, is known to synergize with miR-34a to suppress non-small cell lung tumors in mice [40] .
Notch1 and YY1 are two genes targeted by miR-34a in various cells [23, 32, 41, 42] . Notch signaling is involved in several cellular processes and is a mediator of tumor survival [43] . Furthermore, NOTCH1 receptor (N1IC) interacts with YY1 to regulate the expression of MYC, a regulator of cell proliferation [44] . Notch1 is expressed in endothelial and steroidogenic cells of rodent corpora lutea [45] . In pregnant rats, PGF2A treatment decreased the expression of the cleaved (active) form of the Notch1/4 receptor in the CL and inhibition of Notch1 in the CL resulted in decreased progesterone production and increased apoptosis [24, 25] , suggesting that the luteolytic effect of PGF2A may be mediated through the inhibition of notch signaling. MiR-34a targets several members of the notch signaling pathway (NOTCH1, NOTCH2, DLL1, JAGGED1) in tumors [46] [47] [48] .
YingYang1 is a transcription factor that binds to the promoter region of STAR and inhibits its transcription [49] . STAR regulates the transfer of cholesterol through the mitochondria, the rate-limiting step in steroidogenesis [50, 51]. YY1 increased in a dose-dependent manner in cultured luteal cells treated with PGF2A [26] , suggesting a role for YY1 in the PGF2A-induced decrease in STAR and subsequently, steroidogenesis. In addition, YY1 was also found to associate with the high molecular weight notch complex to suppress the activation of the notch signaling pathway in human K562 erythroleukemic cells and T-cell lymphoblastic leukemia cell lines [52] . In addition to its role in steroidogenesis, studies by Yin et al. [53] showed that YY1 plays a role in cell cycle progression by stimulating the expression of epidermal growth factor receptor (EGFR). MiR-34a inhibited the expression of YY1, resulting in a decrease in the expression of EGFR and cell cycle proteins. Furthermore, YY1 is a negative regulator of p53, which is involved in cellular proliferation and apoptosis [54, 55] .
Given the known functions of YY1, it is reasonable to speculate that an increase in YY1 activity would decrease progesterone production and conversely, a decrease in YY1 activity would increase progesterone production in luteal steroidogenic cells. Indeed, in luteal steroidogenic cells, the miR-34a mimic decreased YY1 expression and increased progesterone production. A rather confounding finding was that in vitro, there was an inverse relationship between miR34a and YY1 concentrations, but both miR-34a and YY1 are greater in MC than developing CL. The results using cultured cells are consistent with the in silico prediction that YY1 is negatively regulated by miR-34a. In the intact CL, it is possible that YY1 is also expressed in other cell types in the CL, for example, endothelial and immune cells, and that expression in these cells is regulated differently than that in steroidogenic cells. The heterogeneous nature of the CL makes it difficult to determine regulation of molecules in specific cell types, and could account for discrepancies in data obtained using specific cell types in vitro compared to whole tissue.
The increase in progesterone production was only 20%, possibly because the miR-34a mimic also decreased NOTCH1, a positive regulator of progesterone [25] . The concentration of NOTCH1 was inversely correlated with that of miR-34a in cultured luteal cells. In the luteal tissue, both NOTCH1 mRNA and miR-34a were upregulated in MC CL versus Day 4 CL, but NOTCH1 protein was unchanged. This indicates that the regulation of NOTCH1 by miR-34a is probably by inhibition of miRNA translation, rather than inducing mRNA degradation [56] .
The regulation of miR-34a expression has been mostly studied in tumors. The transcription factor p53 along with other members of the TP53 family are potent inducers of miR-34a, except for p63, which inhibits miR-34a expression [57] . Thyroid hormone (3,3,5-triiodo-L-thyronine [T3]) induces, whereas estradiol inhibits the expression of miR-34a [58, 59] . Hypoxia is another negative regulator of miR-34a [60] . Finally, miR-34a expression can be suppressed epigenetically by methylation of CpG islands in its promoter [61] . An attempt was made to determine whether typical regulators of luteal cell 
function might also be regulators of miR-34a expression. MiR34a expression was not modulated in luteal cells treated with PGF2A in culture. In addition, neither progesterone nor LH had regulatory effects on miR-34a expression in cultured luteal cells. Therefore, the factor(s) that induces expression of miR34a as the CL matures remains unknown.
We demonstrated that the transition from development to maximal function of the CL is accompanied by an increase in expression of a number of miRNA, suggesting that these miRNA may be involved in regulation of the proteins involved in developmental events in the CL, such as cellular proliferation, angiogenesis, and the capacity to undergo apoptosis. MiR-34a was expressed in fully functional (MC) CL, but expression was low (detected by qPCR) or absent (microarray) in developing CL. Increasing the concentration of miR-34a in cultured luteal cells resulted in changes in progesterone production and proliferation of steroidogenic cells. Notch1 and YY1 were confirmed as targets of miR-34a in luteal cells. Both Notch1 and YY1 are known to regulate cellular proliferation, differentiation, and apoptosis. The decrease in proliferation of luteal cells observed due to increased miR-34a (use of the miR-34a mimic) could be due to miR-34a inhibition of both YY1 and Notch1, leading to a decrease in cellular proliferation (Fig. 11A) . Similarly, the increase in progesterone production observed in response to the miR-34a mimic could be due to its inhibition of YY1, which is a negative regulator of the STAR protein. This effect seemed to be greater than the effect of miR-34a on NOTCH, although downregulation of NOTCH may have reduced the effect of miR-34a on YY1/StAR-mediated progesterone stimulation (Fig. 11B) . Overall, these data provide evidence that miRNA within the CL regulate the transition from development to function and that miR-34a regulates luteal cell proliferation and function via the regulation of NOTCH1 and YY1.
